• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Carlos was it YOU who screwed up rituximab end points?

anonymous

Guest
Man where is he now? The man behind the BILLION dollar failure on that last study’s end points.

The FDA was already in drug name submission. It was a DONE deal!

and then a crash and burn!

what a dropped ball. A slam dunk!

A damn Shame
 




























Three years ago to the day almost.

Sandoz was going to be awarded a biosimilar for rituximab. 6 billion $ drug from Genentech

The FDA had approved everything. They were actually at the approval of the drug name stage that’s how close and committed the whole thing was.

then Carlos on the medical team and some other imbeciles screwed up end points on the final submission

that was the real day Sandoz died. Lost a fortune.

go check the history. Ask some that are still around. It’s truth.
 








Three years ago to the day almost.

Sandoz was going to be awarded a biosimilar for rituximab. 6 billion $ drug from Genentech

The FDA had approved everything. They were actually at the approval of the drug name stage that’s how close and committed the whole thing was.

then Carlos on the medical team and some other imbeciles screwed up end points on the final submission

that was the real day Sandoz died. Lost a fortune.

go check the history. Ask some that are still around. It’s truth.

I asked you are correct. Major debacle. Big loss.